financetom
Business
financetom
/
Business
/
Sinclair Signs Multi-year Deal to Renew NBC Affiliations
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sinclair Signs Multi-year Deal to Renew NBC Affiliations
Jan 15, 2025 8:07 AM

10:44 AM EST, 01/15/2025 (MT Newswires) -- Sinclair (SBGI) and Comcast's ( CMCSA ) NBC said Wednesday they have signed a multi-year deal to renew station affiliations for all 21 of Sinclair's NBC affiliates.

Terms of the agreement weren't disclosed.

The companies also said NBC affiliations were renewed by Sinclair partners in five markets where Sinclair provides sales and other services under a joint sales agreement or master service agreement.

Price: 15.82, Change: +0.25, Percent Change: +1.61

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday as Investors Weigh Tech Rally Against Geopolitical Risks
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday as Investors Weigh Tech Rally Against Geopolitical Risks
Mar 16, 2026
08:55 AM EDT, 03/16/2026 (MT Newswires) -- The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.9% and the actively traded Invesco QQQ Trust (QQQ) was 1.1% higher in Monday's premarket activity as investors weigh gains in technology shares amid the ongoing Middle East conflict. US stock futures were also higher, with S&P 500 Index futures...
Structure Therapeutics Says Aleniglipron Reduces Weight in Phase 2, Extension Studies
Structure Therapeutics Says Aleniglipron Reduces Weight in Phase 2, Extension Studies
Mar 16, 2026
08:51 AM EDT, 03/16/2026 (MT Newswires) -- Structure Therapeutics ( GPCR ) said Monday that its aleniglipron clinical program to potentially treat people with obesity and/or overweight with co-morbidity achieved weight loss in a phase 2 trial and an open label extension study, with no evidence of weight loss plateau. In the phase 2 study, the investigational GLP-1 receptor agonist...
VivoPower International Completes Name, Ticker Change
VivoPower International Completes Name, Ticker Change
Mar 16, 2026
08:53 AM EDT, 03/16/2026 (MT Newswires) -- VivoPower International ( VIVO ) said Monday its shares will begin trading under the new ticker VIVO on Nasdaq, effective before market open. The company said it has also completed its corporate name change to VivoPower ( VIVO ), adding that the change does not affect shareholder rights and no action is required...
Alto Neuroscience Launches $120 Million Private Placement Financing
Alto Neuroscience Launches $120 Million Private Placement Financing
Mar 16, 2026
08:52 AM EDT, 03/16/2026 (MT Newswires) -- Alto Neuroscience ( ANRO ) said Monday that it has initiated a private placement financing for gross proceeds of about $120 million. Under the private placement, Alto Neuroscience ( ANRO ) is offering a total of 2.9 million shares priced at $20 apiece and pre-funded warrants to purchase up to 3.1 million shares...
Copyright 2023-2026 - www.financetom.com All Rights Reserved